Inozyme Pharma, Inc. (INZY) Weighted Average Number of Shares Outstanding, Diluted 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Inozyme Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2024.
  • Inozyme Pharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 61.8 M shares, a 41.3% increase year-over-year.
  • Inozyme Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 51.8 M shares, a 37.3% increase from 2022.
  • Inozyme Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 37.8 M shares, a 60.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 61.8 M +18.1 M +41.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 51.8 M +14.1 M +37.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 56.8 M +13.1 M +30% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 44.9 M +5.16 M +13% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 43.7 M +20 M +84.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 37.8 M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 43.7 M +20 M +84.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 39.7 M +16.2 M +69% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 23.7 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 23.6 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 23.5 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.